Recombinant Human PRDX5 Protein，His

Peroxiredoxin 5 (PRDX5) is a member of the peroxiredoxin family, which plays a pivotal role in cellular redox regulation and antioxidant defense. It is primarily localized in the mitochondria and cytosol, functioning as a scavenger of reactive oxygen species (ROS), thereby mitigating oxidative stress and maintaining cellular homeostasis. Research on PRDX5 has gained momentum due to its implications in various biological processes, including cell proliferation, apoptosis, and inflammation. Dysregulation of PRDX5 has been associated with several diseases, such as cancer, neurodegenerative disorders, and cardiovascular diseases, indicating its potential as a therapeutic target. Recent studies have focused on the recombinant expression of PRDX5 to elucidate its functional mechanisms and structure-function relationships, as well as to explore its therapeutic applications. By producing recombinant PRDX5, researchers aim to gain insights into its enzymatic properties and interactions with other molecular partners, enabling a deeper understanding of its role in oxidative stress response and disease pathology. Furthermore, the availability of recombinant PRDX5 opens up opportunities for the development of novel antioxidant therapies and diagnostic tools, highlighting the significance of ongoing research in this area. As the understanding of PRDX5 continues to evolve, it remains a promising candidate for exploration in the context of aging, inflammation, and various oxidative stress-related conditions.